PDZK1IP1 and systemic sclerosis: As far as our knowledge goes, the present study is the first one investigating the prognostic role of TAPSE/sPAP ratio, alone and in combination with NT-proANP plasma level, in an SSc population free from clinically evident cardiovascular manifestations.